Valuation: Kenvue Inc.

Market Cap 34.34B 30.21B 28.56B 25.91B 48.65B 3,297B 48.94B 342B 132B 1,682B 129B 126B 5,406B P/E 2026 *
18.8x
P/E 2027 * 16.4x
Enterprise Value 41.44B 36.45B 34.47B 31.26B 58.71B 3,978B 59.05B 413B 159B 2,030B 156B 152B 6,523B EV / Sales 2026 *
2.66x
EV / Sales 2027 * 2.56x
Free-Float
98.88%
Yield 2026 *
4.72%
Yield 2027 * 4.82%
1 day+0.45%
1 week+1.19%
Current month-5.30%
1 month-6.73%
3 months-6.53%
6 months+2.05%
Current year+3.65%
1 week 17.56
Extreme 17.555
17.9
1 month 17.49
Extreme 17.49
19.18
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.13
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Exercice

Executive/Senior Manager

32,838 0.0017%
5/21/26 Free

Director

10,309 0.0005%
5/21/26 Free

Chairman

16,036 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
+0.45%+1.19%+8.89%-11.09% 34.19B
+1.91%+2.02%-2.28%+1.84% 340B
+0.14%+0.61%-5.89%+2.91% 133B
+0.53%+0.30%+8.71%+21.33% 68.6B
-2.41%-2.62%-24.52%-22.94% 47.63B
+1.16%-0.80%+10.28%-32.67% 34.18B
-0.17%+0.20%+8.84%+25.82% 20.2B
0.00%+5.42%-11.15%-35.21% 19.52B
+0.08%-1.22%+6.58%+11.87% 17.7B
-1.36%+0.06%-25.42%-12.37% 9.39B
Average +0.01%+0.93%-2.60%-5.05% 72.41B
Weighted average by Cap. +0.75%+1.29%-2.26%-0.26%

Financials

2026 *2027 *
Net sales 15.6B 13.72B 12.97B 11.76B 22.09B 1,497B 22.22B 155B 59.98B 764B 58.55B 57.28B 2,455B 15.97B 14.04B 13.28B 12.04B 22.62B 1,533B 22.75B 159B 61.4B 782B 59.94B 58.65B 2,513B
Net income 1.83B 1.61B 1.52B 1.38B 2.59B 175B 2.6B 18.19B 7.03B 89.49B 6.86B 6.71B 288B 2.1B 1.85B 1.75B 1.59B 2.98B 202B 2.99B 20.93B 8.08B 103B 7.89B 7.72B 331B
Net Debt 7.1B 6.24B 5.9B 5.36B 10.06B 681B 10.12B 70.7B 27.3B 348B 26.65B 26.08B 1,117B 6.53B 5.75B 5.43B 4.93B 9.25B 627B 9.31B 65.05B 25.12B 320B 24.52B 23.99B 1,028B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-09-28 US$17.88 +0.45% 16,029,368
26-09-25 US$17.80 +1.08% 12,581,826
26-09-24 US$17.61 -0.34% 17,494,419
26-09-23 US$17.67 -1.06% 16,168,563
26-09-22 US$17.86 +1.08% 14,290,325
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
17.88USD
Average target price
19.50USD
Spread / Average Target
+9.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock